Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies

Cancer Chemotherapy and Pharmacology
M von MehrenR B Cohen

Abstract

Combination therapy with trabectedin and docetaxel was evaluated in patients with advanced malignancies. In this open-label phase 1 study, docetaxel (60 or 75 mg/m(2); 1-h intravenous infusion) was given on day 1 of a 21-day cycle in combination with escalating doses of trabectedin (0.4-1.3 mg/m(2) by 3-h intravenous infusion, 1 h after docetaxel) and prophylactic granulocyte colony-stimulating factor (G-CSF). Maximum tolerated dose (MTD) as primary objective and safety, plasma pharmacokinetics, and antitumor activity as secondary objectives were assessed. Patients (N = 49) received a median of four cycles of treatment. MTD was 1.3 mg/m(2) trabectedin and 60 mg/m(2) docetaxel for patients with limited and 1.1 mg/m(2) trabectedin and 60 mg/m(2) docetaxel for patients with unlimited prior chemotherapy. Dose-limiting toxicities (during cycle 1) included elevated alanine aminotransferase (ALT) and fatigue in patients with limited prior chemotherapy and elevated ALT and febrile neutropenia in those with unlimited prior chemotherapy. The most common drug-related adverse events were nausea (65 %), fatigue (63 %), and neutropenia (53 %). One patient achieved a complete response. Thirty patients had stable disease, and 11 had stable dis...Continue Reading

References

Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J VerweijQ van Hoesel
Jul 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Q G van HoeselC van Pottelsberghe
Apr 1, 1996·Journal of Pharmacokinetics and Biopharmaceutics·R BrunoL B Sheiner
Dec 1, 1996·American Journal of Clinical Oncology·J H EdmonsonJ B Gerstner
Jul 20, 1999·Journal of Medicinal Chemistry·M Zewail-Foote, L H Hurley
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·M MinuzzoR Mantovani
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E ErbaM D'Incalci
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martee L HensleyDavid R Spriggs
Jun 5, 2003·Cancer Chemotherapy and Pharmacology·Daniela MecoRiccardo Riccardi
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A YovineJ L Misset
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sharyn D BakerMichael A Carducci
Nov 18, 2004·Journal of the National Cancer Institute·Paul A VaseyUNKNOWN Scottish Gynaecological Cancer Trials Group
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Le CesneO S Nielsen
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cristiana SessaNicoletta Colombo
Apr 17, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-C EymardF Joly
Apr 2, 2008·Cancer Chemotherapy and Pharmacology·Wells A MessersmithManuel Hidalgo
May 24, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M von MehrenR B Cohen
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Yves BlayAxel Le Cesne

❮ Previous
Next ❯

Citations

Nov 26, 2015·Expert Opinion on Investigational Drugs·Maurizio D'Incalci, Alberto Zambelli
Sep 13, 2016·Expert Opinion on Pharmacotherapy·Ritika Zijoo, Margaret von Mehren
Feb 1, 2017·Expert Opinion on Pharmacotherapy·Eleonora Teplinsky, Thomas J Herzog

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.